Sep 22 | Mar 22 | Sep 21 | Mar 21 | Sep 20 | |
---|---|---|---|---|---|
Income Statement | - | ||||
Total Revenue | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
EBIT | - | - | - | - | - |
EBITDA | - | - | - | - | - |
Net Income Common Stockholders | - | - | - | - | - |
Balance Sheet | - | ||||
Cash, Cash Equivalents and Short-Term Investments | $ 2.02M | $ 1.89M | $ 3.46M | $ 2.14M | $ 659.66K |
Total Assets | $ 7.58M | $ 7.06M | $ 8.32M | $ 3.20M | $ 3.63M |
Total Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Net Debt | $ ― | $ ― | $ ― | $ ― | $ ― |
Total Liabilities | $ 316.25K | $ 449.86K | $ 719.60K | $ 632.92K | $ 281.39K |
Stockholders Equity | $ 7.28M | $ 6.63M | $ 7.62M | $ 2.57M | $ 3.29M |
Cash Flow | - | ||||
Free Cash Flow | - | - | - | - | - |
Operating Cash Flow | - | - | - | - | - |
Investing Cash Flow | - | - | - | - | - |
Financing Cash Flow | - | - | - | - | - |